Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?
- PMID: 34403399
- DOI: 10.1213/ANE.0000000000005635
Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?
Comment on
-
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019.Anesth Analg. 2021 Apr 1;132(4):930-941. doi: 10.1213/ANE.0000000000005292. Anesth Analg. 2021. PMID: 33093359
References
-
- Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg. 2021;132:930–941.
-
- RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–1645.
-
- Semenzato L, Botton J, Drouin J, et al. Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension. 2021;77:833–842.
-
- Daniels LB, Sitapati AM, Zhang J, et al. Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients. Am J Cardiol. 2020;136:149–155.
-
- Wu CC, Lee AJ, Su CH, Huang CY, Islam MM, Weng YC. Statin use is associated with a decreased risk of mortality among patients with COVID-19. J Clin Med. 2021;10:1450.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
